Similarly, MEF2c (Myocyte enhancer factor 2c) is diminished in aged mice due to increased expression of type-1 interferon (IFN-1) in 5x FAD mouse model representing early microglial changes in AD related pathology (Xue et al., 2021). This evidence concerns the gene MEF2C and Alzheimer disease.